Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS
· Delayed Price · Currency is USD
0.0938
+0.0013 (1.36%)
At close: Dec 5, 2025
Oncotelic Therapeutics Employees
Oncotelic Therapeutics had 26 employees as of December 31, 2024. The number of employees increased by 4 or 18.18% compared to the previous year.
Employees
26
Change (1Y)
4
Growth (1Y)
18.18%
Revenue / Employee
n/a
Profits / Employee
-$64,198
Market Cap
41.42M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
Oncotelic Therapeutics News
- 2 days ago - Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine - GlobeNewsWire
- 3 days ago - Oncotelic and Sapu Nano Announces New PK Data Demonstrating IV Sapu003 Reduces GI Accumulation of Everolimus up to 67-Fold Compared With Oral Dosing - GlobeNewsWire
- 4 days ago - Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs - GlobeNewsWire
- 11 days ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Anticipates Major Fair-Value Uptick Following New Independent JV Valuation - GlobeNewsWire
- 15 days ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) Emerging as Leader with New Independent JV Valuation - GlobeNewsWire
- 5 weeks ago - NetworkNewsAudio Announces Audio Press Release (APR) on Transforming Once-Marginal Drugs into Category-Changing Assets - GlobeNewsWire
- 5 weeks ago - Oncotelic Therapeutics Inc. (OTCQB: OTLC) at Forefront of Effort to Optimize Next-Generation Cancer Therapies - GlobeNewsWire
- 5 weeks ago - Sapu Nano to present at the 2025 San Antonio Breast Cancer Symposium (SABCS) Highlighting Sapu003 (Deciparticle™ Everolimus) - GlobeNewsWire